Co-disposition of chitosan nanoparticles by multi types of hepatic cells and their subsequent biological elimination: the mechanism and kinetic studies at the cellular and animal levels

References

• Mou J, Liu Z, Liu J, Lu J, Zhu W, Pei D. Hydrogel containing minocycline and zinc oxide-loaded serum albumin nanopartical for periodontitis application: preparation, characterization and evaluation. Drug Deliv. 2019;26(1):179–187. doi:10.1080/10717544.2019.157112130822158
   PubMed Web of Science ®Google Scholar
• Yang YH, Wang QQ, Li J, Zhao ZM, Liu Y. Ligustrazine-loaded stealth liposomes: cellular uptake in murine phagocyte cell model and pharmacokinetics in rats. Lat Am J Pharm. 2016;35(1):32–37.
   Web of Science ®Google Scholar
• Ren J, Fang ZJ, Yao L, et al. A micelle- like structure of poloxamer-methotrexate conjugates as nanocarrier for methotrexate delivery. Int J Pharmaceut. 2015;487(1–2):177–186. doi:10.1016/j.ijpharm.2015.04.014
   PubMed Web of Science ®Google Scholar
• Zhao ZM, Wang Y, Han J, et al. Self-assembled micelles of amphiphilic poly(L-phenylalanine)-b-poly(L-serine) polypeptides for tumor-targeted delivery. Int J Nanomed. 2014;9:5849–5862. doi:10.2147/Ijn.S73111
   PubMed Web of Science ®Google Scholar
• Lin J, Hu W, Gao F, et al. Folic acid-modified diatrizoic acid-linked dendrimer-entrapped gold nanoparticles enable targeted CT imaging of human cervical cancer. J Cancer. 2018;9(3):564–577. doi:10.7150/jca.1978629483962
   PubMedGoogle Scholar
• Zhang YN, Poon W, Tavares AJ, Mcgilvray ID, Chan WCW. Nanoparticle-liver interactions: cellular uptake and hepatobiliary elimination. J Control Release. 2016;240:332–348. doi:10.1016/j.jconrel.2016.01.02026774224
   PubMed Web of Science ®Google Scholar
• Walkey CD, Chan WCW. Understanding and controlling the interaction of nanomaterials with proteins in a physiological environment. Chem Soc Rev. 2012;41(7):2780–2799. doi:10.1039/c1cs15233e22086677
   PubMed Web of Science ®Google Scholar
• Walkey CD, Olsen JB, Guo H, Emili A, Chan WC. Nanoparticle size and surface chemistry determine serum protein adsorption and macrophage uptake. J Am Chem Soc. 2012;134(4):2139–2147. doi:10.1021/ja208433822191645
   PubMed Web of Science ®Google Scholar
• Sadauskas E, Danscher G, Stoltenberg M, Vogel U, Larsen A, Wallin H. Protracted elimination of gold nanoparticles from mouse liver. Nanomedicine. 2009;5(2):162–169. doi:10.1016/j.nano.2008.11.00219217434
   PubMed Web of Science ®Google Scholar
• Lacava LM, Garcia VAP, Kückelhaus S, et al. Long-term retention of dextran-coated magnetite nanoparticles in the liver and spleen. J Magn Magn Mater. 2004;272–276:2434–2435. doi:10.1016/j.jmmm.2003.12.852
   Web of Science ®Google Scholar
• Levy M, Luciani N, Alloyeau D, et al. Long term in vivo biotransformation of iron oxide nanoparticles. Biomaterials. 2011;32(16):3988–3999. doi:10.1016/j.biomaterials.2011.02.03121392823
   PubMed Web of Science ®Google Scholar
• Lee S, Kim MS, Lee D, et al. The comparative immunotoxicity of mesoporous silica nanoparticles and colloidal silica nanoparticles in mice. Int J Nanomedicine. 2013;8:147–158. doi:10.2147/IJN.S3953423326190
   PubMed Web of Science ®Google Scholar
• Choi HS, Liu W, Misra P, et al. Renal clearance of quantum dots. Nat Biotechnol. 2007;25(10):1165–1170. doi:10.1038/nbt134017891134
   PubMed Web of Science ®Google Scholar
• Wang H, Thorling CA, Liang X, et al. Diagnostic imaging and therapeutic application of nanoparticles targeting the liver. J Mater Chem B. 2015;3(6):939–958. doi:10.1039/C4TB01611D
   PubMed Web of Science ®Google Scholar
• Bertrand N, Leroux JC. The journey of a drug-carrier in the body: an anatomo-physiological perspective. J Control Release. 2012;161(2):152–163. doi:10.1016/j.jconrel.2011.09.09822001607
   PubMed Web of Science ®Google Scholar
• Jiang LQ, Wang TY, Webster TJ, et al. Intracellular disposition of chitosan nanoparticles in macrophages: intracellular uptake, exocytosis, and intercellular transport. Int J Nanomedicine. 2017;12:6383–6398. doi:10.2147/IJN.S14206028919742
   PubMed Web of Science ®Google Scholar
• Park JK, Utsumi T, Seo YE, et al. Cellular distribution of injected PLGA-nanoparticles in the liver. Nanomedicine. 2016;12(5):1365–1374. doi:10.1016/j.nano.2016.01.01326961463
   PubMed Web of Science ®Google Scholar
• Choi HS, Liu W, Liu F, et al. Design considerations for tumour-targeted nanoparticles. Nat Nanotechnol. 2010;5(1):42–47. doi:10.1038/nnano.2009.31419893516
   PubMed Web of Science ®Google Scholar
• Zhou C, Hao G, Thomas P, et al. Near-infrared emitting radioactive gold nanoparticles with molecular pharmacokinetics. Angewandte Chemie. 2012;51(40):10118–10122. doi:10.1002/anie.20120303122961978
   PubMedGoogle Scholar
• Burns AA, Vider J, Ow H, et al. Fluorescent silica nanoparticles with efficient urinary excretion for nanomedicine. Nano Lett. 2009;9(1):442–448. doi:10.1021/nl803405h19099455
   PubMedGoogle Scholar
• Krebs NE, Hambidge KM. Zinc metabolism and homeostasis: the application of tracer techniques to human zinc physiology. Biometals. 2001;14(3–4):397–412.11831468
   PubMed Web of Science ®Google Scholar
• Paek HJ, Lee YJ, Chung HE, et al. in vivo. Nanoscale. 2013;5(23):11416–11427. doi:10.1039/c3nr02140h23912904
   PubMed Web of Science ®Google Scholar
• Cho M, Cho WS, Choi M, et al. The impact of size on tissue distribution and elimination by single intravenous injection of silica nanoparticles. Toxicol Lett. 2009;189(3):177–183. doi:10.1016/j.toxlet.2009.04.01719397964
   PubMed Web of Science ®Google Scholar
• Kumar R, Roy I, Ohulchanskky TY, et al. In vivo biodistribution and clearance studies using multimodal organically modified silica nanoparticles. ACS Nano. 2010;4(2):699–708. doi:10.1021/nn901146y20088598
   PubMedGoogle Scholar
• Yu M, Zheng J. Clearance pathways and tumor targeting of imaging nanoparticles. ACS Nano. 2015;9(7):6655–6674. doi:10.1021/acsnano.5b0132026149184
   PubMed Web of Science ®Google Scholar
• Mohammad AK, Reineke JJ. Quantitative detection of PLGA nanoparticle degradation in tissues following intravenous administration. Mol Pharm. 2013;10(6):2183–2189. doi:10.1021/mp300559v23510239
   PubMedGoogle Scholar
• Woods A, Patel A, Spina D, et al. In vivo biocompatibility, clearance, and biodistribution of albumin vehicles for pulmonary drug delivery. J Control Release. 2015;210:1–9. doi:10.1016/j.jconrel.2015.05.26925980621
   PubMed Web of Science ®Google Scholar
• Zhang Y, Zhu W, Zhang H, et al. Carboxymethyl chitosan/phospholipid bilayer-capped mesoporous carbon nanoparticles with pH-responsive and prolonged release properties for oral delivery of the antitumor drug, Docetaxel. Int J Pharm. 2017;532(1):384–392. doi:10.1016/j.ijpharm.2017.09.02328903067
   PubMedGoogle Scholar
• Qi L, Xu Z, Jiang X, Li Y, Wang M. Cytotoxic activities of chitosan nanoparticles and copper-loaded nanoparticles. Bioorg Med Chem Lett. 2005;15(5):1397–1399. doi:10.1016/j.bmcl.2005.01.01015713395
   PubMed Web of Science ®Google Scholar
• Hu YL, Qi W, Han F, Shao JZ, Gao JQ. Toxicity evaluation of biodegradable chitosan nanoparticles using a zebrafish embryo model. Int J Nanomedicine. 2011;6:3351–3359. doi:10.2147/IJN.S2585322267920
   PubMed Web of Science ®Google Scholar
• Calvo P, Remunan-Lopez C, Vila-Jato JL, Alonso MJ. Chitosan and chitosan/ethylene oxide-propylene oxide block copolymer nanoparticles as novel carriers for proteins and vaccines. Pharm Res. 1997;14(10):1431–1436.9358557
   PubMed Web of Science ®Google Scholar
• Jonassen H, Kjoniksen AL, Hiorth M. Stability of chitosan nanoparticles cross-linked with tripolyphosphate. Biomacromolecules. 2012;13(11):3747–3756. doi:10.1021/bm301207a23046433
   PubMedGoogle Scholar
• Lopez-Leon T, Carvalho EL, Seijo B, Ortega-Vinuesa JL, Bastos-Gonzalez D. Physicochemical characterization of chitosan nanoparticles: electrokinetic and stability behavior. J Colloid Interface Sci. 2005;283(2):344–351. doi:10.1016/j.jcis.2004.08.18615721903
   PubMed Web of Science ®Google Scholar
• Jiang L, Duan H, Ji X, et al. Application of a simple desolvation method to increase the formation yield, physical stability and hydrophobic drug encapsulation capacity of chitosan-based nanoparticles. Int J Pharm. 2018;545(1–2):117–127. doi:10.1016/j.ijpharm.2018.03.04429601975
   PubMedGoogle Scholar
• Shigematsu M, Tomonaga S, Shimokawa F, et al. Regulatory responses of hepatocytes, macrophages and vascular endothelial cells to magnesium deficiency. J Nutr Biochem. 2018;56:35–47. doi:10.1016/j.jnutbio.2018.01.00829454997
   PubMedGoogle Scholar
• Li H, Zhuang Q, Wang Y, et al. HBV life cycle is restricted in mouse hepatocytes expressing human NTCP. Cell Mol Immunol. 2014;11(2):175–183. doi:10.1038/cmi.2013.6624509445
   PubMed Web of Science ®Google Scholar
• Bailey TJ, Fossum SL, Fimbel SM, Montgomery JE, Hyde DR. The inhibitor of phagocytosis, O-phospho-L-serine, suppresses Muller glia proliferation and cone cell regeneration in the light-damaged zebrafish retina. Exp Eye Res. 2010;91(5):601–612. doi:10.1016/j.exer.2010.07.01720696157
   PubMedGoogle Scholar
• Tait JF, Smith C. Phosphatidylserine receptors: role of CD36 in binding of anionic phospholipid vesicles to monocytic cells. J Biol Chem. 1999;274(5):3048–3054. doi:10.1074/jbc.274.5.30489915844
   PubMedGoogle Scholar
• Antonescu CN, Diaz M, Femia G, Planas JV, Klip A. Clathrin-dependent and independent endocytosis of glucose transporter 4 (GLUT4) in myoblasts: regulation by mitochondrial uncoupling. Traffic. 2008;9(7):1173–1190. doi:10.1111/j.1600-0854.2008.00755.x18435821
   PubMedGoogle Scholar
• Chai GH, Hu FQ, Sun J, et al. Transport pathways of solid lipid nanoparticles across Madin-Darby canine kidney epithelial cell monolayer. Mol Pharm. 2014;11(10):3716–3726. doi:10.1021/mp500467425197948
   PubMed Web of Science ®Google Scholar
• Van Weert AW, Geuze HJ, Groothuis B, Stoorvogel W. Primaquine interferes with membrane recycling from endosomes to the plasma membrane through a direct interaction with endosomes which does not involve neutralisation of endosomal pH nor osmotic swelling of endosomes. Eur J Cell Biol. 2000;79(6):394–399. doi:10.1078/0171-9335-0006210928454
   PubMedGoogle Scholar
• Boal F, Guetzoyan L, Sessions RB, et al. LG186: an inhibitor of GBF1 function that causes Golgi disassembly in human and canine cells. Traffic. 2010;11(12):1537–1551. doi:10.1111/j.1600-0854.2010.01122.x20854417
   PubMedGoogle Scholar
• Lu Y, Dong S, Hao B, et al. Vacuolin-1 potently and reversibly inhibits autophagosome-lysosome fusion by activating RAB5A. Autophagy. 2014;10(11):1895–1905. doi:10.4161/auto.3220025483964
   PubMed Web of Science ®Google Scholar
• Miao Y, Yan PK, Kim H, Hwang I, Jiang L. Localization of green fluorescent protein fusions with the seven Arabidopsis vacuolar sorting receptors to prevacuolar compartments in tobacco BY-2 cells. Plant Physiol. 2006;142(3):945–962. doi:10.1104/pp.106.08361816980567
   PubMedGoogle Scholar
• Jacobs F, Wisse E, De Geest B. The role of liver sinusoidal cells in hepatocyte-directed gene transfer. Am J Pathol. 2010;176(1):14–21. doi:10.2353/ajpath.2010.09013619948827
   PubMedGoogle Scholar
• Wisse E, Jacobs F, Topal B, Frederik P, De Geest B. The size of endothelial fenestrae in human liver sinusoids: implications for hepatocyte-directed gene transfer. Gene Ther. 2008;15(17):1193–1199. doi:10.1038/gt.2008.6018401434
   PubMed Web of Science ®Google Scholar
• Vaezifar S, Razavi S, Golozar MA, et al. Effects of some parameters on particle size distribution of chitosan nanoparticles prepared by ionic gelation method. J Clust Sci. 2013;24(3):891–903. doi:10.1007/s10876-013-0583-2
   Web of Science ®Google Scholar
• Voss EW Jr., Workman CJ, Mummert ME. Detection of protease activity using a fluorescence-enhancement globular substrate. BioTechniques. 1996;20(2):286–291. doi:10.2144/96202rr068825159
   PubMed Web of Science ®Google Scholar
• Hungerford G, Benesch J, Mano JF, Reis RL. Effect of the labelling ratio on the photophysics of fluorescein isothiocyanate (FITC) conjugated to bovine serum albumin. Photochem Photobiol Sci. 2007;6(2):152–158. doi:10.1039/b612870j17277838
   PubMedGoogle Scholar
• Heuser JE, Anderson RG. Hypertonic media inhibit receptor-mediated endocytosis by blocking clathrin-coated pit formation. J Cell Biol. 1989;108(2):389–400. doi:10.1083/jcb.108.2.3892563728
   PubMedGoogle Scholar
• Stoneham CA, Hollinshead M, Hajitou A. Clathrin-mediated endocytosis and subsequent endo-lysosomal trafficking of adeno-associated virus/phage. J Biol Chem. 2012;287(43):35849–35859. doi:10.1074/jbc.M112.36938922915587
   PubMedGoogle Scholar
• Van Weert AW, Dunn KW, Geuze HJ, Maxfield FR, Stoorvogel W. Transport from late endosomes to lysosomes, but not sorting of integral membrane proteins in endosomes, depends on the vacuolar proton pump. J Cell Biol. 1995;130(4):821–834. doi:10.1083/jcb.130.4.8217642700
   PubMedGoogle Scholar
• Granger E, Mcnee G, Allan V, Woodman P. The role of the cytoskeleton and molecular motors in endosomal dynamics. Semin Cell Dev Biol. 2014;31:20–29. doi:10.1016/j.semcdb.2014.04.01124727350
   PubMed Web of Science ®Google Scholar
• Delevoye C, Miserey-Lenkei S, Montagnac G, et al. Recycling endosome tubule morphogenesis from sorting endosomes requires the kinesin motor KIF13A. Cell Rep. 2014;6(3):445–454. doi:10.1016/j.celrep.2014.01.00224462287
   PubMed Web of Science ®Google Scholar
• Cole NB, Sciaky N, Marotta A, Song J, Lippincott-Schwartz J. Golgi dispersal during microtubule disruption: regeneration of Golgi stacks at peripheral endoplasmic reticulum exit sites. Mol Biol Cell. 1996;7(4):631–650. doi:10.1091/mbc.7.4.6318730104
   PubMed Web of Science ®Google Scholar
• Fourriere L, Divoux S, Roceri M, Perez F, Boncompain G. Microtubule-independent secretion requires functional maturation of Golgi elements. J Cell Sci. 2016;129(17):3238–3250. doi:10.1242/jcs.18887027411366
   PubMedGoogle Scholar
• Van Der Linden L, Van Der Schaar HM, Lanke KH, Neyts J, Van Kuppeveld FJ. Differential effects of the putative GBF1 inhibitors Golgicide A and AG1478 on enterovirus replication. J Virol. 2010;84(15):7535–7542. doi:10.1128/JVI.02684-0920504936
   PubMed Web of Science ®Google Scholar
• Brabec M, Blaas D, Fuchs R. Wortmannin delays transfer of human rhinovirus serotype 2 to late endocytic compartments. Biochem Biophys Res Commun. 2006;348(2):741–749. doi:10.1016/j.bbrc.2006.07.12516890915
   PubMedGoogle Scholar
• Fernandez-Borja M, Wubbolts R, Calafat J, et al. Multivesicular body morphogenesis requires phosphatidyl-inositol 3-kinase activity. Curr Biol. 1999;9(1):55–58. doi:10.1016/S0960-9822(99)80048-79889123
   PubMedGoogle Scholar
• Nabi IR, Le PU. Caveolae/raft-dependent endocytosis. J Cell Biol. 2003;161(4):673–677. doi:10.1083/jcb.20030202812771123
   PubMed Web of Science ®Google Scholar
• Matveev S, Li X, Everson W, Smart EJ. The role of caveolae and caveolin in vesicle-dependent and vesicle-independent trafficking. Adv Drug Deliv Rev. 2001;49(3):237–250.11551397
   PubMed Web of Science ®Google Scholar
• Wakabayashi Y, Lippincott-Schwartz J, Arias IM. Intracellular trafficking of bile salt export pump (ABCB11) in polarized hepatic cells: constitutive cycling between the canalicular membrane and rab11-positive endosomes. Mol Biol Cell. 2004;15(7):3485–3496. doi:10.1091/mbc.e03-10-073715121884
   PubMed Web of Science ®Google Scholar
• Kipp H, Arias IM. Trafficking of canalicular ABC transporters in hepatocytes. Annu Rev Physiol. 2002;64:595–608. doi:10.1146/annurev.physiol.64.081501.15579311826281
   PubMedGoogle Scholar
• Esteller A. Physiology of bile secretion. World J Gastroenterol. 2008;14(37):5641–5649. doi:10.3748/wjg.14.564118837079
   PubMedGoogle Scholar
• Souris JS, Lee CH, Cheng SH, et al. Surface charge-mediated rapid hepatobiliary excretion of mesoporous silica nanoparticles. Biomaterials. 2010;31(21):5564–5574. doi:10.1016/j.biomaterials.2010.03.04820417962
   PubMedGoogle Scholar
• Wang Y, Du H, Zhai G. Recent advances in active hepatic targeting drug delivery system. Curr Drug Targets. 2014;15(6):573–599.24606040
   PubMed Web of Science ®Google Scholar
• Ogawara K, Yoshida M, Furumoto K, et al. Uptake by hepatocytes and biliary excretion of intravenously administered polystyrene microspheres in rats. J Drug Target. 1999;7(3):213–221. doi:10.3109/1061186990908550410680977
   PubMed Web of Science ®Google Scholar